Endocan: a new biomarker associated with inflammation in type 2 diabetes mellitus?

E-ISSN： 1099-0895|31|5|479-480

ISSN： 1520-7552

Source： DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol.31, Iss.5, 2015-07, pp. : 479-480

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus

By Mojiminiyi O. A. Abdella N. A.

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 67, Iss. 2, 2007-01 ,pp. : 215-225

Informa Healthcare

Access to resources Recommend Favorite

Saxagliptin: a New DPP-4 inhibitor for the treatment of type 2 diabetes mellitus

By Tahrani Abd Piya Milan Barnett Anthony

Advances in Therapy, Vol. 26, Iss. 7, 2009-07 ,pp. : 736-736

Springer Publishing Company

Access to resources Recommend Favorite

Type 2 diabetes mellitus and bone

JOURNAL OF INTERNAL MEDICINE, Vol. 283, Iss. 2, 2018-02 ,pp. : 140-153

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic variants of PLA2G6 are associated with Type 2 diabetes mellitus and triglyceride levels in a Chinese population

DIABETIC MEDICINE, Vol. 32, Iss. 2, 2015-02 ,pp. : 280-286

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus

By Kanazawa I. Yamaguchi T. Yamauchi M. Yamamoto M. Kurioka S. Yano S. Sugimoto T.

Osteoporosis International, Vol. 22, Iss. 1, 2011-01 ,pp. : 187-194

Springer Publishing Company

Access to resources Recommend Favorite